When simulations were performed in the RA population, the predicted mean 4β-OHC levels were 0.55-fold lower than in healthy individuals (Figure 7C and Table S5), thus reflecting the reduced CYP3A4 abundance in RA patients. This evidence concerns the gene CYP3A4 and rheumatoid arthritis.